Recent Material Events - Sangamo Biosciences, Inc (SGMO)

Filing Date	Description
2008-07-09	Material event, click here to read
2008-04-30	On April 30, 2008, Sangamo BioSciences, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2008. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. ...
2008-04-07	On April 2, 2008, Sangamo BioSciences, Inc. (“Sangamo”) entered into a License Agreement (the “Agreement”) with Open Monoclonal Technology, Inc. (“OMT”), pursuant to which Sangamo will grant a royalty-bearing, non-exclus ...
2008-02-27	On February 27, 2008, Sangamo BioSciences, Inc. (“Sangamo”) entered into a Second Research and License Agreement (the “Second License Agreement”) with Genentech, Inc. (“Genentech”), pursuant to which Sangamo will provide ...
2007-12-03	On December 3, 2007, Sangamo BioSciences, Inc. (the “Company”) announced that H. Ward Wolff has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective December 3, 2007. Since June 2006, Mr. Wolf ...
2007-02-08	Material event, click here to read
2006-12-28	As previously disclosed in a Form 8-K filed by Sangamo BioSciences, Inc. (“Sangamo”) on December 4, 2006 (the “December 4, 2006 Form 8-K”), Sangamo entered into an Asset Purchase Agreement with Edwards Lifesciences LLC, a Delaware... ...
2006-12-04	Material event, click here to read
2006-10-31	Material event, click here to read
2006-10-30	Material event, click here to read